TAIPEI, June 2, 2024 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, is showcasing its prowess in artificial intelligence by partnering with NVIDIA to launch high-end RTX AI PCs. In his keynote at COMPUTEX 2024, NVIDIA CEO Jensen Huang highlighted the dawn of a new computing era driven by generative AI, digital twins, and personal computers evolving into AI factories with digital humans providing professional solutions. Jensen emphasized the challenges... (continue reading...)
MIAMI BEACH, Fla., June 2, 2024 /PRNewswire/ -- Miami Beach is ready to sizzle this summer with a collection of events and experiences that will inspire visitors and locals. From the Miami Beach Classical Music Festival and the American Black Film Festival, to celebrations planned along the beach to support National Pride Month, the destination is ready to welcome all and embrace the changing season. Those spending time on Miami Beach this summer can easily take a... (continue reading...)
REDWOOD CITY, Calif. , June 2, 2024 /PRNewswire/ -- Rokid, a pioneer in augmented reality (AR) technology, has achieved a significant milestone in its crowdfunding campaign for the Rokid AR Lite. With just one day remaining for the early bird pricing, the campaign has soared past $600,000 in pledges. This achievement underscores the growing demand for cutting-edge AR solutions and reinforces Rokid's position as a leader in the industry.
PORT MORESBY, Papua New Guinea, June 2, 2024 /PRNewswire/ -- A team from Pacific Wrecks discovered one of the most famous World War II aircraft in Papua New Guinea. Two weeks later, Papua New Guinea officials signed a Letter of Intent with Poplar, Wisconsin to become Sister Cities.
The twin announcements were made on May 31, 2024 during a live event... (continue reading...)
TAIPEI, June 2, 2024 /PRNewswire/ -- Linker Vision, a pioneer in AI technology, is proud to announce a collaboration with NVIDIA aimed at accelerating vision AI adoption across enterprise applications with large vision models (LVMs). Through this collaboration, Linker Vision is poised to help bring the NVIDIA AI Enterprise software platform for the development and deployment of production-grade generative AI applications to more users worldwide.
Linker Vision's... (continue reading...)
More PRNewswire
View Older Stories-
ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
-
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
-
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
-
Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
-
Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
-
Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
-
Vention to democratize industrial automation using NVIDIA AI technologies
-
OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
-
Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
-
Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
-
Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
-
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
-
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
-
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
-
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
-
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
-
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
-
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
-
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
-
Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
-
Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
-
BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
-
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
-
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
-
Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
-
Taseko Announces that Operations at its Gibraltar Mine have been Suspended
-
PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
-
Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
-
ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
-
Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
-
American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
-
Beverly Hills MD Celebrates Its 10th Anniversary
-
Hyundai Motor America Reports May 2024 Sales
-
Vincent Todd Announces the Introduction of Todd Agriscience
-
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
-
Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients
-
BALEAF & SOJOS to host "Summer it up" summer fashion extravaganza!
-
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
-
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
-
James Avery Artisan Jewelry Opens New Store at Westover Marketplace
-
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
-
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemo
-
ZEEKR Announces May 2024 Delivery Update
-
ALL-TIME BEST MONTHLY SALES FOR THE KIA EV9 AND SPORTAGE SUVs LEAD KIA AMERICA TO SECOND BEST SALES MONTH IN COMPANY HISTORY IN MAY
-
'A Fu, the hutong gentleman'
-
HTX Ventures Invests in Babylon to Advance Trustless Bitcoin Staking
-
Skymizer Launches Groundbreaking LLM Accelerator IP for on-device LLM Inferencing, EdgeThought, the game-changer in on-device GenAI era.
-
Vivacelle Bio's President and Chief Innovation Officer to Present Data Highlighting the Company's Late-Stage Clinical Programs at the BIO International Convention 2024
